Arkolith/Insider Trading/ALPN/Form 4

Durand Remy

Chief Business OfficerALPINE IMMUNE SCIENCES, INC. (ALPN) · full profile →Form 4 · filed May 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
2 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2024Disposed to issuer(D)31K——0
May 20, 2024Disposed to issuer(D)102K——31K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2024Disposed to issuer(D)27K——0
May 20, 2024Disposed to issuer(D)70K——0
May 20, 2024Disposed to issuer(D)113K——0
May 20, 2024Disposed to issuer(D)109K——0
May 20, 2024Disposed to issuer(D)3K——0
May 20, 2024Disposed to issuer(D)78K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001626199-24-000090) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML